OXIDATIVE PHOSPHORYLATION
Other mitochondrial functions
|
MITOCHONDRIAL RESPIRATORY CHAIN: COMPOSITION |
|||||
Complex |
|||||
Enzyme |
CoQ-Cytochrome C |
ATP Synthase |
|||
Inhibitor |
Rotenone |
TTFA malonate |
Antimycin A |
Cyanide |
Oligomycin |
39 |
10 |
10 |
~14 |
||
Mitochondrial |
0 |
||||
Flavoprotein |
Flavin |
|
|
|
|
Iron protein |
Siarczek żelaza |
Cytochrome |
|
||
Other features |
|
|
Copper protein |
|
|
|
|||||
Notes
|
Kompleks I: budowa
Skład
Największy kompleks łańcucha oddechowego
46 białek
7 kodowanych mitochondrialnie białek
39 kodowanych przez nDNA.
Główne podjednostki : flawoproteina; Iron-sulfur protein; Hydrophobic fraction
Subunits involved in Complex I structure
Primarily expressed in heart & skeletal muscle
Disorders: Encephalopathies
Subunits involved in regulation of Complex I activity
Functions: Increased Complex I activity with phosphorylation
Protein involved in Complex I assembly
MYC-induced mitochondrial protein (B17.2L; Mimitin)
Disorder: Childhood encephalopathy
External link: Components
General structure
L-shaped
Hydrophobic arm
Contains mtDNA-encoded subunits
Attaches complex to inner mitochondrial membrane: Embedded in membrane
? Formed by 2 small & large subcomplexes (in Neurospora)
Role in assembly played by: CIA30; CIA84
Hydrophilic peripheral arm
Flavoprotein
Contains NADH binding site & redox active centers
Extends into mitochondrial matrix
Iron�sulphur protein fraction
Facilitates further electron transport to hydrophobic fraction
Location: Parts in
Mitochondrial inner membrane
Mitochondrial matrix
Complex I: Associations (Respirasome)
Supercomplex of I, III, IV
Stabilizes structure of Complex I
Stoichiometry of I:IIII:IV = 1:2:4
Deficiency in other Complexes may produce loss of Complex I function
Complex I: Functions
Transport of electrons from NADH to ubiquinone
Electron source: NADH
Co-factor: Flavin mononucleotide
Transport: via eight redox groups, iron�sulphur clusters
Electron acceptor: Ubiquinone
Ubiquinone function: Transfers of electrons to next complex in the chain (Complex III)
Simultaneous shunting of protons
Out of mitochondrial matrix
Across inner mitochondrial membrane
Into intermembrane space
Stoichiometry: 4H+/2e-
General
Lactate levels & muscle morphology may be normal
Most common clinical phenotype in childhood: Leigh syndrome
Most common cause of Complex I deficiency: Nuclear gene mutations
Complex I ± Other complexes deficient
Alper's
Deficiency: Barth; Infantile CNS
Leber's (LHON)
MERRF
± CNS
Isolated Complex I deficit: mtDNA mutations
MELAS: tRNALeu (A3243G & T3271C)
Myopathy: tRNALeu (T3250C, A3251G & A3303G)
Leber's (LHON): tRNALys (G11778A), ND1 (G3460A) & ND6 (T14484A)
MERRF: tRNALys (G8363A), ND1 (A8344G), tRNASer (MTTS2)
Leigh syndrome: ND4 (G14459A)
Long QT syndrome: tRNAleu (T3394C)
Diabetes & Fanconi syndrome: Multiple deletion
Ataxia, Hypogonadism & Choroidal dystrophy: Multiple deletion
Isolated Complex I deficit: Nuclear mutations
Clinical features: General
Nuclear mutations more common than mitochondrial
Onset: Childhood; Mean = 4 to 5 months
Male:Female = 3.5:1
Prognosis: Death in 1st 2 years in 67%; ? Better with normal blood lactate
Lactic acidosis: Blood 85%; CSF 90%
Inheritance: Usually autosomal recessive
MRI: Abnormal
Specyficzne zespoły
Ciężka noworodkowa kwasica mleczanowa,
Makrocefalia z postępującą leukodystrofią: NDUFV1
Noworodkowa kardiomiopatia z kwasicą mleczanową
encefalomiopatia: NDUFV1
Hepatomegalia z kanałopatią nerkową
Lethal neonatal: NDUFS6
Cardiomyopathy + Encephalomyopathy: NDUFS2; NDUFV2
Childhood encephalopathy: NDUFS1; MYC-induced mitochondrial protein; NDUFA1
COMPLEX II (Succinate Dehydrogenase-CoQ Oxoreductase): Features & Deficiency
Functions
Catalyzes oxidation of succinate to fumarate
Transfers electrons to ubiquinone pool of respiratory chain
Krebs cycle
Composition
Subunits: General
Number: 4
All nuclear encoded
Subunits A & B form succinate dehydrogenase (SDH)
Subunits C & D anchor enzyme to membrane
Flavoprotein: FAD (SDHA; Fp)
Functions: Catalytic site; Covalently bound FAD cofactor
Mutations
Leigh syndrome with Complex II deficiency
Late onset neurodegenerative disorder
Function: Electron transfer between FAD and membrane-bound quinone
Structure: Contains three different iron-sulphur clusters
SDHB mutations
Reduced tumor suppression
Neoplasms: Pheochromocytoma & Paraganglioma
Integral membrane proteins: Bind Fp & Ip to matrix
SDHC & SDHD mutations: Paraganglioma
Location of Complex II
Matrix side of mitochondrial inner membrane
Binding to membrane is dependent on 2 small (15.5 and 13.5 kDa) proteins SDHC & SDHD
COMPLEX III (CYTOCHROME REDUCTASE): Features & Deficiency
Composition
Nuclear subunits
Number: 10
Components
Mitochondrial subunits
Number: 1
Location of Complex III: Inner mitochondrial membrane
Associations
Supercomplex of Complexes I, III, IV
Association of Complexes III & IV may be stabilized by cardiolipin
Defects in cardiolipin remodeling: Barth
Transfers electrons from ubiquinol to cytochrome c
Coupled with transfer of electrons across inner mitochondrial membrane
Contains 3 redox centers
Nie ma zidentyfikowanej mutacji w podjednostce kodowanej jądrowo
Selektywne biochemiczne defekty kompleksu III
Cytochrome b : Mitochondrial; Sporadic
Myopathy ± CNS
Other defects
Tubulopathy, encephalopathy & liver failure
Nuclear subunits
Number: 10
Presumed to play a structural & regulatory role in COX
Mitochondrial subunits
Number: 3
Largest COX subunits
Form catalytic core of COX
Contain the 3 copper atoms & 2 heme A molecules
Serve as prosthetic groups in holoenzyme
Directly involved in electron transfer
Assembly factors related to COX
Essential components of COX biosynthetic pathway
Expression of individual COX subunits
Provide prosthetic groups to the apoenzyme
Factors include: SURF-1; SCO1; SCO2; COX 10; COX 17
Nuclear mutations
General
4 mutations in proteins required for assembly of holocomplex
1 mutation in mRNA binding protein: LRPPRC
No mutations in nuclear encoded structural proteins of COX
Specific mutations
Surfeit-1 (SURF-1) : Leigh syndrome (French-Canadian type)
l Chromosome 9q34; Recessive
COX subunits reduced: All except Va & Vb
SCO2 : Cardioencephalomyopathy, fatal infantile
l Chromosome 22q13; Recessive
COX subunits reduced: I & II
COX10 (Heme A:farnesyltransferase) : Ataxia; Encephalopathy
l Chromosome 17p13.1-q11.1; Recessive
COX subunits reduced: II
LRPPRC: Leigh syndrome; Metabolic acidosis
l Chromosome 2q16; Recessive
Mitochondrial mutations
Sideroblastic anemia, acquired idiopathic
Myopathy ± CNS
Encephalopathy
Spastic paraparesis, Mental retardation & Ophthalmoplegia
Other syndromes associated with Complex IV deficiency
Hyperhomocysteinemia
Fatal
Benign
COMPLEX V (ATP Synthase): Features & Deficiency
Composition
mtDNA encoded: 2 subunits
Nuclear DNA encoded: 14 subunits
Integral membrane component: F0
Composed of at least seven subunits
mtDNA encodes 2 subunits: ATPase 6 & 8
Peripheral moiety: F1
Composed of six subunits
Nuclear DNA encodes all subunits
Uses proton gradient to convert ADP to ATP
Function: Couples proton gradient generated by respiratory chain to ATP synthesis
Proton flow from intermembrane space to matrix
Conversion of ADP + inorganic phosphate to ATP
Mutations
NARP: Intermediate levels (70% to 90%) of T8993G or T8993C mutations in brain & blood
Bilateral striatal necrosis: T9176C mutation
ATP12
Assembly gene
No mutations identified in nuclear encoded subunits
Combined deficiencies of Complexes I, III, IV, and V
Causes: Mutations
mtDNA
Components of mitochondrial translation apparatus encoded by nuclear genes
Synthesis of 13 mitochondrial gene-encoded proteins
Occurs on a dedicated mitochondrial translation apparatus
Requires tRNAs and ribosomal RNAs (rRNAs) encoded in mtDNA
Other factors
Translation factors
Mitochondrial ribosomal (mitoribosome) proteins: All encoded by nuclear genes
Mammalian initiation factors: IF2 & IF3
Elongation factors: EFTu, EFTs, EFG1 & EFG2
Release factor: RF1
Ribosomal recycling factor: RRF
Mitoribosomes
55S particles
Composed of small (28S) & large (39S) subunits
Contain a much higher protein:RNA ratio than bacterial 70S ribosome
Disorders
mtDNA depletion
Thymidine kinase 2 (TK2)
Other nuclear gene mutations
Production
Pathways
Glycogenolysis
Glycolysis
Increased production with
Greater exercise power output
Increased oxygen uptake
Produced even under fully aerobic conditions
Shuttles
Molecules: Lactate exchange facilitators
Membrane transporters: Monocarboxylate transport proteins (MCTs)
Stereo-selective for L-(+)-lactate
pH dependent
Sarcolemmal lactate transporters may have role in regulation of intracellular pH
Inactivity: Reduces MCT1 & MCT4 expression
Training: Increases MCT1 & MCT4 expression
Brief, high intensity exercise: Reduces MCT1 & MCT4 expression
Scaffolding proteins
Cell-cell lactate exchanges between
White-glycolytic & red-oxidative fibres in a working muscle bed
Working skeletal muscle & heart
Tissues of net lactate release & gluconeogenesis
Astrocytes & neurons in brain: Linked to glutamatergic signalling
Intracellular lactate exchanges
Mitochondrial lactate oxidation complex
Proteins involved
Mitochondrial lactate/pyruvate transporters (MCT)
Lactate dehydrogenase
Cytochrome oxidase
Location: Mitochondrial reticulum
Function
Proteins work in conjunction to permit lactate oxidation in actively respiring cells
Establishes concetration & proton gradients
Needed by cells with high mitochondrial densities: Cardiac & Skeletal muscle
Sarcolemma
Protein: Sarcolemmal lactate/pyruvate transporter MCT1 (SLC16A1)
Training effects: Change expression of related proteins
Disposal
Pathways
Oxidative metabolism
Rest: 50%
Exercise: 75%
Cori cycle
Contribution: 25% during exercise
Pathway: Conversion of lactate to glucose (gluconeogenesis)
Increased disposal with
Endurance training: Reduces arterial lactate
Disorders
Epidemiology: 2 patients
Genetics: Heterozygous missense mutations; Lys204Glu, Gly472Arg
SLC16A1 protein
Transporter defect location: Erythrocytes & Muscle
Clinical: Pain after exercise
Lab: Erythrocyte lactate clearance rates decreased to 40% to 50% of normal control